6-K ·Filed Aug 18, 2026

SNN

SMITH & NEPHEW PLC
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001654954-26-007708
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine equity compensation filing with no trading signal. The CEO's retention of 27,613 shares post-vesting is consistent with normal insider holding patterns. Monitor the next 20-F annual report for any changes in executive compensation structure or performance metrics.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
SNN ▼ -7.92% at T+20d
NEUTRAL call ✗ call lost -7.92% · α vs SPY -6.61% · entry $30.19 → $27.80
Next anchor: T+60d in 6w
Latest observation: T+30 -5.99% FF3 residual α
Entry anchored
Aug 18, 04:08 AM ET
via 1-min bar
T+1d
-2.91%
call -2.91% · α -3.12%
$29.31
settled 6w ago
T+5d
-3.21%
call -3.21% · α -3.01%
$29.22
settled 5w ago
T+20d
-7.92%
call -7.92% · α -6.61%
$27.80
settled 16d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

Smith & Nephew filed a routine 6-K reporting the vesting of 2024 restricted share awards for CEO Deepak Nath under the company's Restricted Share Plan 2024. The vesting occurred on August 17, 2026, with 47,105 shares acquired, of which 19,492 were sold to cover tax liabilities and 27,613 were retained. This is a standard equity compensation event with no material financial or strategic implications for the company.

Key Facts

  • CEO Deepak Nath received 47,105 ordinary shares upon vesting of 2024 Restricted Share Plan awards on August 17, 2026.
  • Of the 47,105 shares, 19,492 were sold to cover tax obligations and 27,613 were retained.
  • The transaction was executed on the London Stock Exchange at a price of £10.898231 per share.
  • This is a routine equity compensation disclosure under UK Market Abuse Regulation.

Financial Impact

No material financial impact. CEO retained 27,613 shares valued at approximately £300,000 based on the transaction price.

dilution

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
OTC
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
50% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-007708
Document: 0001654954-26-007708-index-headers.html0001654954-26-007708
Document: 0001654954-26-007708-index.html0001654954-26-007708
Document: 0001654954-26-007708.txt0001654954-26-007708
30 reports for SNN
Performance horizon
88% Hit rate 7 of 8 directional calls best @ T+20▲ +8.02%Jun 30, 2026
Filters
Rows
Reports for SNN — sortable, filterable
TypeNow
Sep 16, 2026
16d ago
6-K
NEUTRAL ★ 3/10
$27.80 $26.82▼ −3.53%▼ −6.09%$26.42 (−4.96%)
Sep 16, 2026
16d ago
6-K
NEUTRAL ★ 3/10
$27.80 $26.82▼ −3.53%▼ −6.09%$26.42 (−4.96%)
Sep 11, 2026
21d ago
6-K
NEUTRAL ★ 4/10
$27.50 $27.56▲ +0.22%▲ +0.44%$26.42 (−3.93%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 4/10
$27.62 $27.78▲ +0.58%▲ +1.08%$26.42 (−4.34%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 4/10
$27.62 $27.78▲ +0.58%▲ +1.08%$26.42 (−4.34%)
Sep 9, 2026
23d ago
6-K
NEUTRAL ★ 2/10
$27.80 $28.06▲ +0.94%▲ +1.27%$26.42 (−4.96%)
Sep 8, 2026
24d ago
424B5
NEUTRAL ★ 4/10
$27.87 $28.01▲ +0.50%▲ +1.62%$26.42 (−5.20%)
Sep 2, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$28.66 $27.62▼ −3.63%▼ −2.67%$26.42 (−7.82%)
Sep 2, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$28.66 $27.62▼ −3.63%▼ −2.67%$26.42 (−7.82%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$28.97 $27.80▼ −4.04%▼ −4.12%$26.42 (−8.80%)
Showing 10 of 30

US Market Status

Market Closed — Opens Mon (64h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access